Recent publications · Crossref
5 total works indexed
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
· 2008 · cited 3,176x
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
· 2019 · cited 2,991x
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
· 2019 · cited 2,837x
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
· 2019 · cited 1,955x
- Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
· 2020 · cited 1,565x
via Crossref · CC0